Hostname: page-component-848d4c4894-4hhp2 Total loading time: 0 Render date: 2024-06-02T18:00:34.758Z Has data issue: false hasContentIssue false
  • English
  • Français

Absence of cerebrospinal fluid antineuronal antibodies in schizophrenia spectrum disorders – CORRIGENDUM

Published online by Cambridge University Press:  10 July 2018

Tatiana Oviedo-Salcedo ,
Lot de Witte ,
Tania Kümpfel ,
René S. Kahn ,
Peter Falkai ,
Peter Eichhorn ,
Jurjen Luykx  and
Alkomiet Hasan
Rights & Permissions [Opens in a new window]

Summary

This notice describes a correction to the above mentioned paper.

Type
Corrigendum
Information
The British Journal of Psychiatry , Volume 213 , Issue 3 , September 2018 , pp. 561
Copyright
Copyright © The Royal College of Psychiatrists 2018 

In the reference list, number 11 is stated incorrectly. The correct reference for 11 is:

Dalmau J, Lancaster E, Martinez-Hernandez E, Rosenfeld MR, Balice-Gordon R. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. The Lancet Neurology 2011; 10(1):63–74.

The authors regret the error.

References

Oviedo-Salcedo, T, De Witte, L, Kümpfel, T, Kahn, R, Falkai, P, Eichhorn, P, Luykx, J, Hasan, A. Absence of cerebrospinal fluid antineuronal antibodies in schizophrenia spectrum disorders. The British Journal of Psychiatry 2018; 1–3. doi:10.1192/bjp.2018.24.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.